Department of Cardiac Surgery, Innsbruck Medical University, Innsbruck, Austria.
Transpl Int. 2010 Jun;23(6):589-93. doi: 10.1111/j.1432-2277.2009.01024.x. Epub 2009 Dec 14.
Donor hypernatremia is known to be associated with initial graft dysfunction in liver transplantation. Controversial data exist regarding the impact of sodium dysregulation on patient survival after heart transplantation (HTX). The aim of this study was to investigate the influence of donor sodium levels on survival in a large cohort of heart transplant recipients from the Eurotransplant registry. From 1997 to 2005, all consecutive adult HTX performed in the Eurotransplant region were included into this study (n = 4641 patients). Multivariate analysis was applied to investigate possible clinical predictors for 1-year post-transplant survival after cardiac transplantation (donor sodium levels, donor age, donor cause of death, recipient age, primary disease, urgency status, cold ischemia time). In multivariate analysis, recipients receiving a donor heart with serum sodium level lower than 130 mmol/l or higher than 170 mmol/l had a 1.25-fold higher risk for 1-year post-transplant mortality than patients with normal donor sodium ranges (P = 0.007). Other independent risk factors for impaired 1-year survival were recipient age, the indication for transplantation and the urgency status of the recipient. Our study demonstrates that hyponatremia as well as hypernatremia show a strong U-shaped correlation with poor survival after cardiac transplantation. Accurate donor management to avoid electrolyte disorder seems to be crucial for ensuring good quality of donor hearts.
供体高钠血症已知与肝移植中初始移植物功能障碍有关。关于钠调节对心脏移植(HTX)后患者生存的影响存在争议数据。本研究的目的是调查供体钠水平对 Eurotransplant 登记处的大量心脏移植受者生存的影响。1997 年至 2005 年,Eurotransplant 区域内进行的所有连续成人 HTX 均纳入本研究(n = 4641 例患者)。应用多变量分析来调查心脏移植后 1 年移植存活的可能临床预测因素(供体钠水平、供体年龄、供体死因、受体年龄、原发性疾病、紧急状态、冷缺血时间)。多变量分析显示,与正常供体钠范围的患者相比,接受血清钠水平低于 130mmol/l 或高于 170mmol/l 的供体心脏的受体 1 年移植后死亡率增加 1.25 倍(P = 0.007)。1 年生存受损的其他独立危险因素包括受体年龄、移植适应证和受体的紧急状态。我们的研究表明,低钠血症和高钠血症与心脏移植后生存不良呈强 U 形相关。准确的供体管理以避免电解质紊乱对于确保供体心脏的良好质量似乎至关重要。